MENU

3 market-beating tech shares to buy this month

Abstract digital and technology background.

The Australian tech sector certainly has been a great place to be invested over the last 12 months.

During this time the S&P/ASX 200 Info Tech (Index: ^AXIJ) (ASX: XIJ) has surged over 29% higher.

While there’s no guarantee it will continue its outperformance over the next 12 months, I think there are a few potential market-beaters in the sector worth taking a closer look at.

Three that I like are listed below:

ELMO Software Ltd (ASX: ELO)

ELMO is a leading provider of integrated cloud human resources and payroll software solutions. Its increasingly popular SaaS, cloud-based platform provides organisations with a centralised approach to managing an employee’s lifecycle from hire to retire. The company has been growing at an impressively strong rate this year and looks set to outperform its prospectus forecasts by some distance. Fortunately, with the ANZ market opportunity estimated to be worth upwards of US$770 million per year, it could potentially continue growing at a strong rate for some time to come.

NEXTDC Ltd (ASX: NXT)

According to Gartner, the cloud computing market is expected to grow to be worth US$411 billion in 2020 from an estimated US$305.8 billion in 2018. As the incredible rise of cloud computing continues, I expect demand for data centre services to rise strongly as well. This should put NEXTDC and its network of world class data centres in a great position to deliver bumper profit growth over the medium term. Though it is worth noting that its shares trade on a sky-high earnings multiple, making them a high risk investment option.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a medical technology company which specialises in breast imaging analytics and analysis software. Its software is regulatory cleared (FDA, CE, TGA), patent protected, clinically validated, used in 36 countries, and has over 273 supporting science publications. The key market at this stage, in my opinion, is the United States. It counts some of the largest and most respected cancer hospitals and screening sites in the country as customers, leading to it handling 3.2% of all breast cancer screening in the U.S. in FY 2018. Pleasingly, management is targeting a market share of 9% in FY 2019. I expect this to lead to another significant jump in annualised recurring revenues.

Looking for the next major tech boom? This could be it.

Japanese Billionaire’s Prediction Will Give You Goosebumps

When a veritable investing and entrepreneurial genius speaks, it pays to listen.

In fact, he's now preparing a $100B "war chest" to invest entirely in this "terrifying" new technology, which could spell huge profits for investors.

Click here to learn about this technology and how you can profit!

Motley Fool contributor James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia owns shares of and has recommended ELMOSFTWRE FPO and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!